Home › Gastrointestinal Stromal Tumors › Utah › Salt Lake City
Gastrointestinal Stromal Tumors clinical trials in Salt Lake City, UT
3 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, Salt Lake City
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
RecruitingPhase 2
- Huntsman Cancer Institute, Salt Lake City
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
RecruitingPhase 1
- University of Utah, Salt Lake City
Gastrointestinal Stromal Tumors trials in other cities
- Miami, FL8 studies
- Boston, MA7 studies
- New York City, NY7 studies
- Houston, TX6 studies
- Philadelphia, PA6 studies
- San Diego, CA5 studies
- Nashville, TN5 studies
- Portland, OR5 studies
- Omaha, NE5 studies
- Los Angeles, CA4 studies
- Dallas, TX4 studies
- Rochester, MN4 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.